Merck U.S. patent rights for products
In accordance with Section 287(a) of Title 35 of the United States Code, the following list identifies Merck's rights in U.S. patents associated with the relevant product. This list may be a subset of Merck's rights in U.S. patents directed to the relevant product.
Activyl®
(indoxacarb)
U.S. Patent No. 8,475,818
BRAVECTO®
(fluralaner) chews Flavored chews for dogs
U.S. Patent No 7,662,972
U.S. Patent No 8,022,089
U.S. Patent No 8,492,311
U.S. Patent 11,285,101
BOVILIS Nasalgen 3 PMH
Live cattle vaccine
U.S. Patent No. 9,642,905
U.S. Patent No. 9,662,382
BOVILIS® Coronavirus
Live Bovine Coronavirus Vaccine
U.S. Patent No. 10,434,168 B2
BRAVECTO®
(fluralaner) topical solution dogs and cats
U.S. Patent No 7,662,972
U.S. Patent No 8,022,089
U.S. Patent No 8,492,311
U.S. Patent No. 9,532,978
U.S. Patent No. 9,173,870
BRAVECTO® Plus
(fluralaner and moxidectin) Topical Solution cats
U.S. Patent No 7,662,972
U.S. Patent No 8,022,089
U.S. Patent No 8,492,311
U.S. Patent No. 9,173,870
U.S. Patent No 9,532,978
CIRCUMVENT CML®
Porcine Circovirus Vaccine, Type 2, Killed Baculovirus Vector, Mycoplasma Hyopneumoniae
U.S. Patent No. 9,084,768 B2
FORTEGRA®
Live eimeria vaccine
U.S. Patent No. 9,050,281
INNOVAX™ ILT-IBD
Live virus poultry vaccine
U.S. Patent No. 11,596,687
INNOVAX™ ND-IBD
Live virus poultry vaccine
U.S. Patent No. 10,308,956
INNOVAX™ ND-ILT
Live virus poultry vaccine
U.S. Patent No. 8,932,604
Nobivac®: Canine Flu Bivalent
Canine influenza virus
U.S. Patent No. 7,959,929
U.S. Patent No. 9,345,758
U.S. Patent No. 8,246,962
Nobivac®: Canine Flu H3N8
Canine influenza virus
U.S. Patent No. 7,959,929
U.S. Patent No. 9,345,758
Nobivac®: Lyme
Borrelia Burgdorferi Bacterin
U.S. Patent No. 8,137,678
U.S. Patent No. 8,414,901
Nuflor Gold®
Florfenicol
U.S. Patent No. 8,034,845
Posatex® Otic Suspension
Orbifloxacin, Mometasone Furoate monohydrate and Posaconazole, Suspension
U.S. Patent No. 8,084,445
U.S. Patent No. 8,609,645
Prestige® 2
Equine influenza (EIV), equine herpesvirus type 1 (EHV-1) and equine herpesvirus type 4 (EHV-4)
U.S. Patent No. 10,555,998
Prestige® 4
Eastern and Western encephalomyelitis (EEE and WEE) viruses, equine influenza virus (EIV) and tetanus
U.S. Patent No. 10,555,998
Prestige® 5
Equine herpesvirus type 1 (EHV-1), equine herpesvirus type 4 (EHV-4), Eastern and Western encephalomyelitis (EEE and WEE) viruses, and equine influenza virus (EIV)
U.S. Patent No. 10,555,998
Prestige® V+ WNV with Havlogen®
Encephalomyelitis-Rhinopneumonitis-Influenza West Nile Virus Vaccine, Eastern and Western, Killed Virus, Killed Flavivirus Chimera, Tetanus Toxoid
U.S. Patent No. 8,048,429
U.S. Patent No. 8,133,712
U.S. Patent No. 10,555,998
Resflor Gold®
Florfenicol and Flunixin Meglumine
U.S. Patent No. 8,044,102
Zilmax®
Zilpaterol hydrochloride
U.S. Patent No. 8,580,772
U.S. Patent No. 7,207,289
Zuprevo®
Tildipirosin
U.S. Patent No. 8,227,429
Revised Date: September 2024
BELSOMRA®
(suvorexant) Tablets
U.S. Patent No. 7,951,797
U.S. Patent No 10,098,892
BRIDION®
(sugammadex sodium injection) For intravenous use
U.S. Patent No. RE44,733
DELSTRIGO®
(doravirine/lamivudine/tenofovir disoproxil fumarate) Tablets
U.S. Patent No. 8,486,975
U.S. Patent No. 10,603,282
U.S. Patent No. 10,842,751
DIFICID®
(fidaxomicin) for Oral Suspension
U.S. Patent No. 7,863,249
U.S. Patent No. 7,378,508
U.S. Patent No. 9,808,530
DIFICID®
(fidaxomicin) Tablets for oral use
U.S. Patent No. 7,863,249
U.S. Patent No. 7,378,508
EMEND®
(aprepitant) Capsules 125/80 mg
U.S. Patent No. 8,258,132
EMEND®
(aprepitant) Capsules 40mg
U.S. Patent No. 8,258,132
EMEND®
(aprepitant) for oral suspension (125 mg)
U.S. Patent No. 8,258,132
ISENTRESS®
(raltegravir) Chewable Tablets for oral use
U.S. Patent No. 7,754,731
U.S. Patent No. 8,771,733
ISENTRESS®
(raltegravir) Film-coated Tablets for oral use
U.S. Patent No. 7,754,731
U.S. Patent No. 8,771,733
JANUMET®
(sitagliptin/metformin HCl) Tablets
U.S. Patent No. 7,326,708
JANUMET® XR
(sitagliptin and metformin HCl extended-release) Tablets
U.S. Patent No. 7,326,708
JANUVIA®
(sitagliptin) Tablets
U.S. Patent No. 7,326,708
JUVISYNC
(sitagliptin and simvastatin) Tablets
U.S. Patent No. 7,326,708
KEYTRUDA®
(pembrolizumab) For Injection
U.S. Patent No. 8,354,509
U.S. Patent No. 8,900,587
U.S. Patent No. 9,834,605
U.S. Patent No. 11,117,961
LAGEVRIO™
(molnupiravir) Capsules 200mg
U.S. Patent No. 11,331,331
PIFELTRO®
(Doravirine) Tablets
U.S. Patent No. 8,486,975
PREVYMIS®
(letermovir) injection, for intravenous use
U.S. Patent No. 8,513,255
PREVYMIS®
(letermovir) Tablets, for Oral Use
U.S. Patent No. 8,513,255
RECARBRIO®
(imipenem/cilastatin and relebactam) For intravenous use
U.S. Patent No. 8,487,093
SEGLUROMET®
(ertugliflozin and metformin) Tablets for oral use
U.S. Patent No. 8,080,580
SIVEXTRO®
(tedizolid phosphate) Powder for Infusion and Oral tablets
U.S. Patent No. 7,816,379
U.S. Patent No. 8,420,676
STEGLATRO®
(ertugliflozin) Tablets for oral use
U.S. Patent No. 8,080,580
STEGLUJAN®
(ertugliflozin and sitagliptin) Tablets for oral use
U.S. Patent No. 8,080,580
VERQUVO®
VERQUVO® (vericiguat) tablets, for oral use
U.S. Patent No. 8,420,656
U.S. Patent No. 10,736,896
WELIREG™
(belzutifan)
U.S. Patent No. 9,908,845
U.S. Patent No. RE49,948
WINREVAIR™
(sotatercept) For Injection
U.S. Patent No. 7,612,041
U.S. Patent No. 7,951,771
ZEPATIER®
(elbasvir/grazoprevir) Tablets for oral use
U.S. Patent No. 8,871,759
U.S. Patent No. 7,973,040
ZERBAXA®
(ceftolozane sulfate/tazobactam sodium) Powder for infusion
U.S. Patent No. 7,129,232
ZINPLAVA™
(bezlotoxumab) Injection, for intravenous use
U.S. Patent No. 8,257,709
ZOLINZA®
(vorinostat) Capsules
U.S. Patent No. 7,456,219
U.S. Patent No. 8,093,295
Revised Date: September 2024
CAPVAXIVE™
PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE
U.S. Patent No. 11,116,828
ERVEBO®
EBOLA ZAIRE VACCINE, LIVE
8,012,489B2
GARDASIL®
HUMAN PAPILLOMAVIRUS QUADRIVALENT (TYPES 6, 11, 16, 18) VACCINE, RECOMBINANT
U.S. Patent No. 7,476,389
GARDASIL®9
HUMAN PAPILLOMAVIRUS 9-VALENT VACCINE, RECOMBINANT
U.S. Patent No. 7,476,389
VAXNEUVANCE®
PNEUMOCOCCAL 15 VALENT CONJUGATE VACCINE
Suspension for Intramuscular Injection
U.S. Patent No. 8,192,746
Revised Date: September 2024
